omega-n-methylarginine has been researched along with olmesartan in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 841 | 185 | 554 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, M; Hiramatsu, O; Kajiya, F; Ogasawara, Y; Shimokawa, H; Yada, T | 1 |
1 other study(ies) available for omega-n-methylarginine and olmesartan
| Article | Year |
|---|---|
Role of endogenous hydrogen peroxide during angiotensin type 1 receptor blockers administration in pacing-induced metabolic coronary vasodilatation in dogs in vivo.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Biological Factors; Cardiac Pacing, Artificial; Catalase; Coronary Vessels; Deoxyguanosine; Diabetes Mellitus, Experimental; Dogs; Female; Hydrogen Peroxide; Ibuprofen; Imidazoles; Infusions, Intravenous; Male; Microcirculation; Myocardium; omega-N-Methylarginine; Superoxide Dismutase; Tetrazoles; Vasodilation | 2013 |